New technology could allow creation of
fertilized embryos using non-reproductive cells.
Not exact matches
After the removal and fertilization of eggs with the
use of in vitro fertilization (IVF), some women with multiple
embryos (
fertilized eggs) may decide to have a single
embryo transferred to the womb even when multiple
embryos are available (elective single
embryo transfer eSET).
The
embryo is created
using an egg from a female intended parent or an egg donor which is
fertilized by sperm provided by a male partner or a sperm donor.
A 2017 experiment, also in China,
used CRISPR to edit DNA in normal, presumably viable
fertilized eggs, or one - cell human
embryos.
This will mark the start of the first clinical trial in China
using human embryonic stem (ES) cells, and the first one worldwide aimed at treating Parkinson's disease
using ES cells from
fertilized embryos.
If the cells can be
fertilized and develop into viable
embryos, and if human ES cells turn out to have similar powers, such cells could allow researchers to get around some of the expense and ethical questions that arise from
using donated eggs for therapeutic cloning experiments.
Thus far, the Newcastle team has worked with abnormally
fertilized human eggs that will not develop into viable
embryos; the new money will allow them to
use normal, leftover eggs from IVF therapy.
The only correct way forward is
using normally
fertilized zygotes and
embryos.
Both methods —
using existing
fertilized embryos and creating new
embryos specifically for research purposes — are controversial.
This legislation is notable because the Swiss Constitution broadly prohibits research
using human
embryos and even sets controls over the number of eggs that may be
fertilized and developed outside a woman's body during fertility treatments.
Embryonic stem cells can be derived from in vitro
fertilized (IVF)
embryos that are developed in excess of those needed for the procedure
used to enable infertile couples to have children.